Comparative safety of multiple doses of erythropoietin for the treatment of traumatic brain injury: A systematic review and network meta-analysis.

Front Neurol · 2022 · PMC9793776 · PMID 36582613

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

EPO did not significantly reduce mortality in patients with TBI compared with placebo but showed a trend toward lower mortality in patients with TBI as the total dose increased.

also in 53,322 other papers

a significant trendno p-value reported

EPO had a significant trend advantage in the prognosis of patients.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.